























pharmaceutical technology | drug development news & views updated dailyhome - pharmaceutical technology









































































skip to site menu
skip to page content















pt
menu
search















 
sections
homenewsanalysisfeaturescomment & opinionprojectsdata insightssectorsclinical trialsdrug manufacturerstherapy areacardiovascularcentral nervous systemimmunologyinfectious diseaseoncologyrespiratorypricing and market accessthemesartificial intelligencecorporate governancecloudcybersecurityenvironmental sustainabilityinternet of thingsroboticssocial responsibilitycovid-19insightsdealsjobsfilingspatentssocial mediacompaniescompany a-zcompany categoriesproducts & servicescompany releaseswhite papersvideosbuyer's guidespartner contenteventsbuy reportsexcellence awardsinnovation rankingsmagazinenewsletters 

globaldata
about us
advertise with us
contact us
our marketing solutions
globaldata reports
visit globaldata
 

from our partners
control and confidence in clinical data management
connecting healthcare tech with the life sciences industry
optimizing cell & gene therapy processes
collaboration and expertise in contract analytical chemistry
a new generation of cdmo services
accelerating biopharmaceutical innovation
precision medicine and digital health innovation for disease diagnosis, care and treatment
enabling process intensification in biopharma manufacturing
the next chapter of clinical trial services
putting quality first in the pharma supply chain
pharmaceutical grade silicone manufacturer
maximising molecule potential
 






newsanalysissectionsfeaturescomment & opinionprojectsdata insightslatesttreating alcohol addiction: filling the medication gapradiopharmaceutical deals drive sector growth despite supply crisisthe ai advantage in discovering new medicines sectorssectionsclinical trialsdrug manufacturerstherapy areapricing and market accesslatestwho and st jude start distributing paediatric cancer medicines amid us aid cutspermeapadsuper bowl ad for copycat weight loss drugs stokes pharma power debatethemessectionsartificial intelligencecloudcorporate governancecybersecurityenvironmental sustainabilityinternet of thingsroboticssocial responsibilitycovid-19foreign direct investmentlatestuk awards £82.6m to ai drug discovery companiesgsk stays optimistic on vaccines amidst us and china woes lb bohleinsightssectionsdealsjobsfilingspatentssocial medialatestimmedica to buy marinus pharmaceuticals for $151mprivate equity deals in pharmaceutical in canada remained flat in q3 2024q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industrycompaniessectionscompany a-zcompany categoriesproducts & servicescompany releaseswhite papersvideosbuyer's guidespartner contentlatest43rd annual jp morgan healthcare conference 2025the spoken revolution in rater training assessmenthow ai is streamlining cell and gene therapy manufacturingeventsbuy reportsnewsletters pt











features

eu reshapes htas: is the industry ready for it?
new eu regulations aim to speed up health technology assessments (htas), but the pharma industry raises logistical concerns.

  akosua mireku
















analyst comment

dmd market expected to grow to $5.2bn in the 7mm by 2033

  globaldata healthcare












news

newleos secures $93.5m for neuropsychiatric treatments








analyst comment

trump presidency signals potential downturn in nih sbir/sttr grant funding for biopharma drugs



news

galderma enters fierce european atopic dermatitis market with nemluvio approval



news

ec approves csl’s andembry to stop hereditary angioedema attacks



news

health canada approves novartis’ fabhalta for pnh with haemolytic anaemia



news

aardvark prices $94.2m ipo to fund development of prader-willi syndrome drug







analysis

				view more
			











features

trump’s tariffs will trickle down the clinical trial chain
  abigail beaney













analyst comment

obesity market to reach $173.5bn by 2031
  globaldata healthcare













analyst comment

impact of proposed us tariffs on pharmaceutical fdi in canada, mexico, china and europe
  globaldata healthcare













features

treating alcohol addiction: filling the medication gap
  ross law



















sign up for our daily news round-up!
give your business an edge with our leading industry insights.



sign up








themes

				view more
			






news

uk awards £82.6m to ai drug discovery companies
the uk announced the funding at the ai action summit in paris where it abstained from signing a declaration on an inclusive approach to ai.











more themes
artificial intelligence
cloud
corporate governance
cybersecurity
environmental sustainability
internet of things
robotics
social responsibility
covid-19
 









features

the ai advantage in discovering new medicines 



news

ai’s potential in women’s health exciting, says gates foundation leader



news

shionogi awarded $375m from hhs for preventative covid-19 injectable



news

pfizer believes in the metaverse: will healthcare thaw the technology’s winter?






data insights

                view more
            







data insights

cell & gene therapy: the leading companies in recombinant aav gene therapy revealed
the pharmaceutical industry continues to be a hotbed of patent innovation. activity is driven by the evolution of treatment paradigms,...









discover data insights powered by our proprietary data
understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
find out more







data insights

leading clinical trials companies in the artificial intelligence theme



data insights

private equity deals in pharmaceutical in canada remained flat in q3 2024



data insights

bnt-325 by biontech for malignant mesothelioma: likelihood of approval






more insights


coronavirus disease 2019 (covid-19) vaccine by china national biotec group for coronavirus disease 2019 (covid-19) pneumonia: likelihood of approval
fosigotifator by calico life sciences for unspecified central nervous system disorders: likelihood of approval
paclitaxel by innoup farma for solid tumor: likelihood of approval
nmda regulator by boehringer ingelheim international for unspecified central nervous system disorders: likelihood of approval
cd19-cd22 car-t cells by shanghai biomed-union biotechnology for unspecified b-cell lymphomas: likelihood of approval





 



buyer's guides

						view more
					










 buyer's guides

leading strategic intelligence solutions for the pharmaceutical industry










 buyer's guides

key lead generation providers and technology solutions for the pharmaceutical industry










 buyer's guides

leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry










 buyer's guides

active pharmaceutical ingredients and intermediates for the pharmaceutical industry







globaldata reports

							view more
						











														migraine in 68 markets - disease overview, product profiles, patient flow, ...

$10995









														innovation in pharma: recombinant virus-like particles (vlps)...

$250









														migraine in major markets, disease management, epidemiology, pipeline asses...

$10995









														m&a in the contract manufacturing industry: implications and outlook - ...

$4995









														cell & gene therapy in pharma: car-t cell based therapies...

$250















digital magazine

            view more
          






latest issue

pharma technology focus
pharma technology focus is our digital magazine, free to read online on all devices. click the magazine cover to read the latest issue. you can subscribe for free to have each new issue delivered to your inbox.
subscribe





















sign up for our daily news round-up!
give your business an edge with our leading industry insights.
give your business an edge with our leading industry insights. 


close





close








sign up to the newsletter: in brief













































industry *
academia & education
aerospace, defense &
                                                    security
agriculture
asset management
automotive
banking & payments
chemicals
construction
consumer
foodservice
government, trade bodies
                                                    and ngos
health & fitness
hospitals & healthcare
                                                
hr, staffing &
                                                    recruitment
insurance
investment banking
legal services
management consulting
marketing & advertising
                                                
media & publishing
medical devices
mining
oil & gas
packaging
pharmaceuticals
power & utilities
private equity
real estate
retail
sport
technology
telecom
transportation &
                                                    logistics
travel, tourism &
                                                    hospitality
venture capital







country *
uk
usa
afghanistan
åland islands
albania
algeria
american samoa
andorra
angola
anguilla
antarctica
antigua and barbuda
argentina
armenia
aruba
australia
austria
azerbaijan
bahamas
bahrain
bangladesh
barbados
belarus
belgium
belize
benin
bermuda
bhutan
bolivia
bonaire, sint eustatius and saba
bosnia and herzegovina
botswana
bouvet island
brazil
british indian ocean territory
brunei darussalam
bulgaria
burkina faso
burundi
cambodia
cameroon
canada
cape verde
cayman islands
central african republic
chad
chile
china
christmas island
cocos islands
colombia
comoros
congo
democratic republic of
                                                the congo
cook islands
costa rica
côte d"ivoire
croatia
cuba
curaçao
cyprus
czech republic
denmark
djibouti
dominica
dominican republic
ecuador
egypt
el salvador
equatorial guinea
eritrea
estonia
ethiopia
falkland islands
faroe islands
fiji
finland
france
french guiana
french polynesia
french southern territories
gabon
gambia
georgia
germany
ghana
gibraltar
greece
greenland
grenada
guadeloupe
guam
guatemala
guernsey
guinea
guinea-bissau
guyana
haiti
heard island and mcdonald islands
                                                
holy see
honduras
hong kong
hungary
iceland
india
indonesia
iran
iraq
ireland
isle of man
israel
italy
jamaica
japan
jersey
jordan
kazakhstan
kenya
kiribati
north korea
south korea
kuwait
kyrgyzstan
lao
latvia
lebanon
lesotho
liberia
libyan arab jamahiriya
liechtenstein
lithuania
luxembourg
macao
macedonia, the former
                                                yugoslav republic of
madagascar
malawi
malaysia
maldives
mali
malta
marshall islands
martinique
mauritania
mauritius
mayotte
mexico
micronesia
moldova
monaco
mongolia
montenegro
montserrat
morocco
mozambique
myanmar
namibia
nauru
nepal
netherlands
new caledonia
new zealand
nicaragua
niger
nigeria
niue
norfolk island
northern mariana islands
norway
oman
pakistan
palau
palestinian territory
panama
papua new guinea
paraguay
peru
philippines
pitcairn
poland
portugal
puerto rico
qatar
réunion
romania
russian federation
rwanda
saint helena, ascension and tristan da cunha
saint kitts and nevis
saint lucia
saint pierre and miquelon
saint vincent and the grenadines
                                                
samoa
san marino
sao tome and principe
saudi arabia
senegal
serbia
seychelles
sierra leone
singapore
slovakia
slovenia
solomon islands
somalia
south africa
south georgia and the south
                                                sandwich islands
spain
sri lanka
sudan
suriname
svalbard and jan mayen
swaziland
sweden
switzerland
syrian arab republic
taiwan
tajikistan
tanzania
thailand
timor-leste
togo
tokelau
tonga
trinidad and tobago
tunisia
turkey
turkmenistan
turks and caicos islands
tuvalu
uganda
ukraine
united arab emirates
us minor outlying islands
uruguay
uzbekistan
vanuatu
venezuela
vietnam
british virgin islands
us virgin islands
wallis and futuna
western sahara
yemen
zambia
zimbabwe
kosovo







i would also like to subscribe to:






















                                                                                                                        pharma technology focus : pharmaceutical technology focus (monthly)                                                                                                                        












                                                                                                                                thematic take (monthly)                                                                                                                        














visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. 

















subscribe



                                                    visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information of
                                                    your rights in respect of your personal data and how you can unsubscribe from future marketing communications. our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. 
                                

































thank you for subscribing
view all newsletters from across the globaldata media network.
close












		the leading site for news and procurement in the pharmaceutical industry
















about us
advertise with us
license our content
contact us
editorial approach
newsletters
our marketing solutions
 

privacy policy
terms and conditions
sitemap


				powered by
				

© verdict media limited 2025


















































lost password back ⟶
login
register











get new password

 











lost password?



login

 


registration is disabled. 

























